HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasminogen: an important hemostatic parameter in septic patients.

AbstractBACKGROUND:
Previously we observed in some but not all septic patients a low plasma concentration of plasminogen.
OBJECTIVES:
To investigate prospectively whether plasma levels of plasminogen or the ratio of plasminogen to alpha-2-antiplasmin have a prognostic value for survival from sepsis and to study the variation of other hemostatic parameters during septicemia.
PATIENTS:
The study population consisted of 45 consecutive patients with septicemia, 15 non-septic patients from the same intensive care unit and 30 healthy volunteers.
MEASUREMENTS AND MAIN RESULTS:
Plasminogen concentrations were significantly lower (p < 0.001) in plasma of septic patients (median 0,62 IU/ml range: 0.15-1,06) than in plasma of healthy controls (median 1.00 IU/ml, range: 0.75-1.10) or of non-septic intensive care patients (median 1.00 IU/ml, range: 0.82-1.08). Among the other parameters tested, plasminogen activator inhibitor (PAI-1) antigen concentration and PAI activity were similar in septic and non-septic intensive care patients, but higher than in healthy controls. Concentrations of elastase-alpha-1-protease inhibitor or of thrombin-antithrombin complexes were higher in septic patients than in non-septic intensive care patients or healthy controls. A degraded form of plasminogen of 38 kDa was detected by Western blot analysis in the plasma of septic patients, but not in plasma of non-septic intensive care patients or controls. Plasminogen alone or the ratio of plasminogen to antiplasmin were good markers for survival from septicemia. E.g. for plasminogen at a cut off of 0.65 IU/ml, sensitivity was 90.5% and specificity 66.7%, whereas for the ratio of plasminogen over antiplasmin at a cut off ratio of 0,65 IU/ml, sensitivity was 95.2% and specificity 70.8%.
CONCLUSION:
Plasminogen or the ratio of plasminogen to antiplasmin are sensitive markers for survival in patients with septicemia.
AuthorsC Duboscq, I Quintana, E Bassilotta, G E Bergonzelli, P Porterie, B Sassetti, A S Haedo, N Wainsztein, E K Kruithof, L Kordich
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 77 Issue 6 Pg. 1090-5 (Jun 1997) ISSN: 0340-6245 [Print] Germany
PMID9241738 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • alpha-2-Antiplasmin
  • Plasminogen
Topics
  • Adult
  • Aged
  • Hemostasis
  • Humans
  • Middle Aged
  • Plasminogen (analysis)
  • Prognosis
  • Prospective Studies
  • Sepsis (blood, physiopathology)
  • alpha-2-Antiplasmin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: